Cargando…
High soluble CD30, CD25 and IL-6 may identify patients with worse survival in CD30+ cutaneous lymphomas and early mycosis fungoides
Histopathology alone cannot predict outcome of patients with CD30+ primary cutaneous lymphoproliferative disorders (CD30CLPD) and early mycosis fungoides (MF). To test the hypothesis that serum cytokines/cytokine receptors provide prognostic information in these disorders, we measured soluble CD30 (...
Autores principales: | Kadin, Marshall E., Pavlov, Igor, Delgado, Julio C., Vonderheid, Eric C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3278552/ https://www.ncbi.nlm.nih.gov/pubmed/22071475 http://dx.doi.org/10.1038/jid.2011.351 |
Ejemplares similares
-
CD30+ Large Cell Transformation of Mycosis Fungoides During Pregnancy
por: Naeini, Farahnaz Fatemi, et al.
Publicado: (2013) -
Amlodipine-induced hypersensitivity reaction mimicking CD30(+) mycosis fungoides
por: Gochoco, Ashley, et al.
Publicado: (2016) -
CD30+ Transformed Mycosis Fungoides Associated with Sweet-like Dermatosis
por: ANDRÉ, Florine, et al.
Publicado: (2022) -
Evidence linking atopy and staphylococcal superantigens to the pathogenesis of lymphomatoid papulosis, a recurrent CD30+ cutaneous lymphoproliferative disorder
por: Kadin, Marshall E., et al.
Publicado: (2020) -
Paraneoplastic scleroderma in the setting of CD30(+) large cell transformation of mycosis fungoides
por: Queen, Dawn, et al.
Publicado: (2019)